Literature DB >> 8373897

Influence of blood sampling from venipunctures and catheter systems on serial determinations of prothrombin activation fragment 1 + 2 and thrombin-antithrombin III complex.

G Hafner1, H Schinzel, W Ehrenthal, C Wagner, U Konheiser, R Zotz, J Lotz, R Blank, L S Weilemann, W Prellwitz.   

Abstract

To evaluate the influence of different blood sampling techniques on test results of thrombin-antithrombin III complex (TAT) and prothrombin fragment 1 + 2 (F1 + 2) serial determinations were performed. In six groups of nonrandomized patients (ten patients each) the concentrations of the coagulation markers of blood samples from central catheters (internal jugular, caval, Shaldon, pulmonary artery) and peripheral cannulas (17G and 18G) were compared with those of blood samples obtained simultaneously from direct venipunctures of the contralateral arm. Medians and 25th-75th percentiles of TAT and F1 + 2 concentrations of plasmas obtained from central catheters were not different from those taken from venipunctures. When delta mean values (catheter - venipuncture) were calculated negative results were obtained, indicating lower concentrations measured from blood sampled through central catheters with the exception of blood that taken from Shaldon catheters. Only for TAT concentrations significantly were lower values measured in blood samples taken from internal jugular catheters when compared with blood samples obtained from direct venipunctures. Significantly higher TAT concentrations were determined in blood samples obtained from Shaldon catheters. For both coagulation markers correlations were found between concentrations in blood samples from central catheters and venipunctures. In blood samples taken from peripheral venous cannulas only F1 + 2 concentrations correlated with the concentrations found in samples from direct venipuncture. In contrast to F1 + 2, TAT concentrations measured from blood samples via peripheral cannulas were determined significantly higher than those taken from direct venipunctures.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373897     DOI: 10.1007/bf01701734

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  13 in total

1.  Multicentric evaluation of a new assay for prothrombin fragment F1+2 determination.

Authors:  H D Bruhn; J Conard; M Mannucci; J Monteagudo; H Pelzer; J C Reverter; M Samama; A Tripodi; C Wagner
Journal:  Thromb Haemost       Date:  1992-10-05       Impact factor: 5.249

2.  Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.

Authors:  H Pelzer; A Schwarz; N Heimburger
Journal:  Thromb Haemost       Date:  1988-02-25       Impact factor: 5.249

3.  Determination of human prothrombin activation fragment 1 + 2 in plasma with an antibody against a synthetic peptide.

Authors:  H Pelzer; A Schwarz; W Stüber
Journal:  Thromb Haemost       Date:  1991-02-12       Impact factor: 5.249

4.  Increased thrombin activity during thrombolysis.

Authors:  R Seitz; H Blanke; G Prätorius; B E Strauer; R Egbring
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

5.  Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses.

Authors:  E M Conway; K A Bauer; S Barzegar; R D Rosenberg
Journal:  J Clin Invest       Date:  1987-12       Impact factor: 14.808

6.  Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.

Authors:  J A Hoek; A Sturk; J W ten Cate; R J Lamping; F Berends; J J Borm
Journal:  Clin Chem       Date:  1988-10       Impact factor: 8.327

7.  Thrombin generation in acute promyelocytic leukemia.

Authors:  K A Bauer; R D Rosenberg
Journal:  Blood       Date:  1984-10       Impact factor: 22.113

8.  The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation.

Authors:  K A Bauer; R D Rosenberg
Journal:  Blood       Date:  1987-08       Impact factor: 22.113

9.  Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin--antithrombin complex.

Authors:  J M Teitel; K A Bauer; H K Lau; R D Rosenberg
Journal:  Blood       Date:  1982-05       Impact factor: 22.113

10.  Serial determinations of PF4 and beta TG: comparisons between multiple venipunctures vs a catheter infusion system.

Authors:  W Strauss; G Cella; C Myers; A A Sasahara
Journal:  Thromb Haemost       Date:  1988-06-16       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.